Treatment for Cough, Congestion, and Runny Nose
For viral upper respiratory symptoms (common cold), use first-generation antihistamine-decongestant combinations (such as dexbrompheniramine 6 mg or azatadine 1 mg with pseudoephedrine 120 mg, both twice daily) as the primary treatment, supplemented with nasal saline irrigation and non-narcotic analgesics for symptom relief. 1, 2
Treatment Algorithm Based on Symptom Duration and Pattern
Acute Symptoms (≤10-14 days): Viral Rhinosinusitis
The most recent guideline 2 emphasizes that viral rhinosinusitis is self-limited, peaking within 3 days and resolving within 10-14 days. Antibiotics should NOT be used as bacterial infection complicates only 0.5-2% of cases. Discolored nasal discharge alone does not indicate bacterial infection—it reflects neutrophil presence from inflammation, not bacteria.
Primary treatment approach:
First-generation antihistamine-decongestant combinations are the evidence-based first-line therapy 1. These work through anticholinergic properties rather than antihistamine effects. Start once daily at bedtime for several days before advancing to twice-daily dosing to minimize sedation.
Nasal saline irrigation provides mechanical cleansing with low risk and minor symptom improvement 2. Higher volume irrigations appear superior.
Analgesics: Choose based on symptom profile 2:
- Acetaminophen helps nasal obstruction and rhinorrhea but not sore throat, malaise, or cough
- NSAIDs improve malaise, sneezing, headache, and ear pain but not nasal discharge
Decongestant Options
- Topical oxymetazoline: Use for maximum 3-5 days only to avoid rebound congestion (rhinitis medicamentosa) 2
- Oral pseudoephedrine: Can be used beyond 5 days but counsel patients about elevated blood pressure/heart rate risks 2
- Oral phenylephrine: The FDA advisory committee discouraged its use in 2023 based on multiple RCTs showing ineffectiveness 2
What NOT to Use for Viral Symptoms
- Newer-generation antihistamines (terfenadine, loratadine) are ineffective for acute viral cough 1
- First-generation antihistamines alone without decongestants show no clinically significant effect on nasal obstruction, rhinorrhea, or sneezing 2
- Guaifenesin and dextromethorphan: Evidence of efficacy is lacking 2
Chronic or Persistent Symptoms (>10-14 days): Consider Allergic Rhinitis
If symptoms persist beyond 2 weeks or follow a chronic pattern, suspect upper airway cough syndrome (UACS) from allergic rhinitis 1.
Treatment hierarchy for allergic rhinitis:
Nasal corticosteroids are first-line for allergic rhinitis-associated cough 1, 3. Mometasone furoate significantly improves both daytime cough and nasal symptoms with good tolerability 3.
Add nasal saline irrigation if corticosteroids alone are insufficient. One study showed superior cough relief with nasal saline compared to fluticasone in house dust mite allergy 4.
Nonsedating antihistamines are more effective for allergic rhinitis than nonallergic rhinitis 1
Nasal cromolyn or oral leukotriene inhibitors can be considered as alternatives 1
Critical Pitfalls to Avoid
Sedation from first-generation antihistamines: While meta-analyses question whether sedation is truly greater than newer agents, initiate therapy once daily at bedtime before advancing to twice-daily dosing 1. Avoid first-generation antihistamines in older adults 2.
Rebound congestion: Warn patients explicitly about rhinitis medicamentosa with topical decongestants beyond 3 days 2.
Overuse of antibiotics: Only 0.5-2% of viral upper respiratory infections develop bacterial complications. Purulent discharge alone does not indicate bacterial infection 2.
Combination product adverse effects: Analgesic-decongestant combinations have significantly more adverse effects than control (number needed to harm = 14) 5. However, antihistamine-decongestant combinations show no significant increase in adverse effects compared to placebo 5.
Special Populations
For patients with contraindications to first-generation antihistamines (glaucoma, symptomatic benign prostatic hypertrophy), ipratropium bromide nasal spray can be effective, though evidence is limited to small prospective studies 1.
The evidence for combination products in young children is lacking—current data supports effectiveness only in adults and older children 5.